© 2021 MJH Life Sciences and Diagnostic Imaging. All rights reserved.
© 2021 MJH Life Sciences™ and Diagnostic Imaging. All rights reserved.
April 04, 2021
Investigators used a hypothetical cohort of men with prostate cancer to test the benefits associated with MRI imaging before biopsy in regard to age-based and risk-stratified screening.
March 12, 2021
USPSTF lung cancer screening recommendation update; Cancer screenings and COVID-19; and CT and unintentional weight loss.
February 19, 2021
Mammography "Sweet Spot" Recall Rate; MRI for Early-Stage Testicular Cancer Follow-Up; COVID-19 and Body Self-Attack; Plus, Global Radiology
February 15, 2021
Using MRI – rather than CT – for post-surgical monitoring can effectively detect cancer relapse without exposing men to unnecessary radiation.
February 12, 2021
Results show bi-parametric MRI not only shortens scan times and eliminates gadolinium exposure, but it also finds more clinically significant prostate cancers.
COVID-19 Vaccine-Related Adenopathies on Breast MRI; Baseline Mammography at 40; Cherenkov Imaging to Improve Radiation Therapy Improvement; and Sexual Harassment and Gender Discrimination in Radiology
February 08, 2021
Cherenkov imaging uses special BeamSite cameras to capture radiation beam interaction with tissue, making radiation oncology treatments a visual process.
February 05, 2021
Clinical trial results show MRI as more accurate and less intrusive at diagnosis for men with a clinical suspicion of prostate cancer.
February 02, 2021
Men with intermediate-risk prostate cancer can be successfully treated with MRI-guided high-intensity focused ultrasound without experiencing incontinence or erectile dysfunction.
Prognosis for these patients is poor, but MRI can help providers reliably stage their disease.